Area of research
Infectious Diseases · Health
Research interest
Research interests include Vaccine Coverage and Hesitancy, SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, and Respiratory viral infections research.
In a shifting policy era: California provider knowledge and practice of medical exemption laws during the COVID-19 pandemic.
Risk of Immune Thrombocytopenic Purpura Recurrence Following Second Measles-Containing Vaccine Dose.
Influenza Vaccination During Pregnancy and Infant Influenza in the First 6 Months of Life.
Recombinant Zoster Vaccination and Risk of Postherpetic Neuralgia or Zoster Ophthalmicus.
Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023.
Religious Service Attendance, COVID-19 Vaccine Attitudes, and COVID-19 Vaccination Status: A Vaccine Safety Datalink Member Survey, 2022-2023.
Attitudes of California school personnel on potential COVID-19 vaccine mandates and state law SB277 to remove nonmedical vaccine exemptions.
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023.
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.
Overview of U.S. COVID-19 vaccine safety surveillance systems.
Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals.
Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study.
Incidence and Risk of Coronavirus Disease 2019 Hospitalization Among Unvaccinated Children.
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
Safety of COVID-19 mRNA Vaccination Among Young Children in the Vaccine Safety Datalink.
Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017-18 through 2022-23 influenza seasons.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink
Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines
Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021